Key result
Machine learning identifies age as the strongest predictor of NT-proBNP levels, explaining ~37% of variance.
Why the study?
Few studies have comprehensively assessed the factors correlated with NT-proBNP levels in individuals with cardiovascular health.
Cross-Sectional (n=12,526)
Effect estimate: R2 = 36.91%
In individuals without cardiovascular disease, age, gender, red blood cell count, race/ethnicity, systolic blood pressure, and total protein are the strongest predictors of circulating NT-proBNP levels, highlighting the need for personalized reference ranges.
Hypothesis-generating for age-adjusted NT-proBNP ranges; prospective validation required before clinical adoption.
N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) is important for diagnosing and predicting heart failure or many other diseases. However, few studies have comprehensively assessed the factors correlated with NT-proBNP levels in people with cardiovascular health. We used data from the 1999–2004 National Health and Nutrition Examination Survey (NHANES). Machine learning was employed to assess 66 factors that associated with NT-proBNP levels, including demographic, anthropometric, lifestyle, biochemical, blood, metabolic, and disease characteristics. The predictive power of the model was assessed using five-fold cross-validation. The optimal features predicting NT-proBNP levels were identified using univariate and step-forward multivariate models. Weighted least squares regression (WLS) was applied for supplementary analysis. Finally, the relationship between the corresponding features and NT-proBNP was validated using weighted and adjusted generalized additive models (GAM). We included 12, 526 participants without cardiovascular diseases. In the univariate model, age exhibited the highest association with NT-proBNP levels (the coefficient of determination (R2) = 36.91%). The multivariate models revealed that age, gender, red blood cell count, race/ethnicity, systolic blood pressure, and total protein level were the top six predictors of NT-proBNP. GAM demonstrated a noteworthy non-linear association between NT-proBNP and age, red blood cell count, systolic blood pressure, and total protein. Our study contributes to explaining the biological mechanisms of NT-proBNP and will facilitate the design of relevant cohort studies. We underscore the significance of assessing various population subgroups when employing NT-proBNP as a biomarker, and the need for developing innovative clinical algorithms to establish personalized levels.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2025) conducted a cross-sectional in Without cardiovascular diseases (n=12,526). Demographic, clinical, and laboratory factors was evaluated on Association with NT-proBNP levels (variance explained) (R2 = 36.91%). Machine learning analysis identified age, gender, red blood cell count, race/ethnicity, systolic blood pressure, and total protein as the top predictors of NT-proBNP levels, with age alone explaining 36.91% of the variance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: